Immunotherapy in lung cancer

More research and new treatment options are needed in all stages of lung cancer. To this end immunotherapy needs a revival in view of recent improved technologies and greater understanding of the underlying biology. In this review we discuss mechanisms of tumour immunotherapy, non-specific, specific...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 1998-08, Vol.78 (3), p.282-288
Hauptverfasser:	AL-MOUNDHRI, M, O'BRIEN, M, SOUBERBIELLE, B. E
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents BCG Vaccine - therapeutic use Biological and medical sciences Humans Immunotherapy Immunotherapy, Adoptive Interferons - therapeutic use Interleukin-2 - therapeutic use Levamisole - therapeutic use Lung cancer Lung Neoplasms - therapy Medical sciences Pharmacology. Drug treatments Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	More research and new treatment options are needed in all stages of lung cancer. To this end immunotherapy needs a revival in view of recent improved technologies and greater understanding of the underlying biology. In this review we discuss mechanisms of tumour immunotherapy, non-specific, specific and adoptive, with particular reference to a direct therapeutic action on all subtypes of lung cancer.
ISSN:	0007-0920 1532-1827
DOI:	10.1038/bjc.1998.486